Show simple item record

POVEZANOST LIPIDNOG STATUSA SA 25-HIDROKSI VITAMINOM D: STUDIJA PRESEKA KOD BOLESNIKA SA KRAJNJIM STADIJUMOM BOLESTI BUBREGA

dc.creatorMilinković, Neda
dc.creatorSarić, Marija
dc.creatorJovičić, Snežana
dc.creatorMirković, Duško
dc.creatorLežaić, Višnja
dc.creatorIgnjatović, Svetlana
dc.date.accessioned2020-06-26T10:28:57Z
dc.date.available2020-06-26T10:28:57Z
dc.date.issued2020
dc.identifier.issn1452-8258
dc.identifier.urihttp://farfar.pharmacy.bg.ac.rs/handle/123456789/3624
dc.description.abstractBackground:Some observational studies indicate an association of 25-hydroxy vitamin D (25(OH)D) insufficiency and atherogenic cholesterol concentrations. The aim of this study was to investigate relationship between 25(OH)D concentrations and lipid parameters in end stage renal disease (ESRD) patients, separately for predialysis, hemodialysis and peritoneal dialysis patients.Methods:We have adjusted 25(OH)D concentrations for seasonal variability with cosinor analysis, and performed all further analysis using these corrected 25(OH)D concentrations. Concentrations of 25(OH)D and the lipid parameters were determined in 214 ESRD patients and 50 control group participants. The analysis included the measurement of 25(OH)D by HPLC, apolipoprotein (Apo) AI, ApoB andLp(a) by nephelometry, total cholesterol (TC), high-densitylipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) by spectrophotometry and manually calculated ApoB/ApoAI and LDL-C/HDL-C ratio.Results:ESRD patients with adjusted 25(OH)D concentrations of ≤ 50 nmol/L had significantly higher TC (P =0.005) and ApoAI (P = 0.049). Significantly higher HDL-C (P = 0.011) and ApoAI (P = 0.020) were found in hemodialysis patients with the 25(OH)D concentrations of ≤ 50 nmol/L. The other analyzed lipid parameters differed significantly between predialysis, hemodialysis and peritoneal dialysis patients with 25(OH)D concentrations of <50 nmol/L. Conclusions:Our study indicate the significant relationship between 25(OH)D repletion and optimal concentrations of lipid parameters in ESRD patients. Further research is necessary to explain whether joint evaluation of vitamin D status and lipid abnormalities could improve cardiovascular outcome in ESRD patients.en
dc.description.abstractUvod: Opservacione studije ukazuju na povezanost nedostatka 25-hidroksi vitamin D (25(OH)D) i koncentracija aterogenog holesterola. Cilj ove studije bio je da se ispita međusobna povezanost 25(OH)D i lipidnih parametara kod bolesnika sa krajnjim stadijumom bolesti bubrega (ESRD) posebno kod predijaliznih, bolesnika na hemodijalizi i peritonalnoj dijalizi. Metode: Podesili smo koncentracije 25(OH)D za sezonsku varijaciju koristeći kosinor analizu, i u daljem ispitivanju smo koristili korigovane koncentracije 25(OH)D. Koncentracije 25(OH)D i lipidnih parametara su određene za 214 ESRD bolesnika i 50 učesnika kontrolne grupe. Analizirali smo koncentracije 25(OH)D metodom HPLC, apolipoproteina (Apo) AI, ApoB i Lp(a) nefelometrijski, ukupnog holesterola (TC), lipoproteina velike gustine (HDL-C), lipoproteina male gustine (LDL-C) i triglicerida (TG) spektro fotometrijski i ručno preračunavali indekse ApoB/ApoAI i LDL-C/HDLC. Rezultati: ESRD bolesnici sa korigovanim 25(OH)D 50 nmol/L su imali značajno viši TC (P = 0,005) i ApoAI (P = 0,049). Značajno više koncentracije HDL-C (P = 0,011) i ApoAI (P = 0,020) smo dobili kod hemodijaliznih bolesnika sa 25(OH)D koncentracijama 50 nmol/L. Ostali analizirani lipidni parametri su bili značajno različiti između analiziranih grupa bolesnika sa 25(OH)D koncentracijama < 50 nmol/L. Zaključak: Naša studija ukazuje na značajnu povezanost dovoljnih nivoa 25(OH)D i optimalnih koncentracija lipidnih parametara kod ESRD bolesnika. Potrebna su dalja istraživanja da bi se objasnilo da li zajednička procena statusa vitamina D i lipidnih abnormalnosti mogu da poboljšaju kardiovaskularni ishod kod ESRD bolesnika.sr
dc.language.isoensr
dc.publisherBeograd : Društvo medicinskih biohemičara Srbijesr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175035/RS//sr
dc.rightsopenAccesssr
dc.sourceJournal of Medical Biochemistrysr
dc.subjectlipid parameterssr
dc.subject25-hydroxy vitamin Dsr
dc.subjectend stage renal diseasesr
dc.subjectdialysissr
dc.subjectlipidni parametrisr
dc.subject25-hidroksi vitamin Dsr
dc.subjectkrajnji stadijum bolesti bubregasr
dc.subjectdijalizasr
dc.titleLIPID STATUS ASSOCIATION WITH 25-HYDROXY VITAMIN D: CROSS SECTIONAL STUDY OF END STAGE RENAL DISEASE PATIENTSen
dc.titlePOVEZANOST LIPIDNOG STATUSA SA 25-HIDROKSI VITAMINOM D: STUDIJA PRESEKA KOD BOLESNIKA SA KRAJNJIM STADIJUMOM BOLESTI BUBREGAsr
dc.typearticlesr
dc.rights.licenseBYsr
dcterms.abstractМилинковић, Неда; Игњатовић, Светлана; Лежаић, Вишња; Мирковић, Душко; Јовичић, Снежана; Сарић, Марија; ПОВЕЗAНОСТ ЛИПИДНОГ СТAТУСA СA 25-ХИДРОКСИ ВИТAМИНОМ Д: СТУДИЈA ПРЕСЕКA КОД БОЛЕСНИКA СA КРAЈНЈИМ СТAДИЈУМОМ БОЛЕСТИ БУБРЕГA; ПОВЕЗAНОСТ ЛИПИДНОГ СТAТУСA СA 25-ХИДРОКСИ ВИТAМИНОМ Д: СТУДИЈA ПРЕСЕКA КОД БОЛЕСНИКA СA КРAЈНЈИМ СТAДИЈУМОМ БОЛЕСТИ БУБРЕГA;
dc.citation.volume39
dc.citation.issue3
dc.citation.spage309
dc.citation.epage317
dc.citation.rankM23~
dc.identifier.wos000543795100006
dc.identifier.doi10.2478/jomb-2019-0032
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/7844/LIPID_STATUS_ASSOCIATION_pub_2020.pdf
dc.type.versionpublishedVersionsr


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record